Role of GLP-1 receptor agonist in T2DM with Atherosclerotic Cardiovascular Disease- Dr PC Manoria at CSI Con 2021
Advertisement
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are used to treat type 2 Diabetes Mellitus. GLP-1 RAs drugs are very effective in lowering blood sugar levels. These Drugs are also beneficial in improving heart health and kidney function.
In this Video, Dr. Prof. P.C. Manoria explains the Role of Glucagon-like peptide-1 receptor agonists in T2DM with Atherosclerotic Cardiovascular Disease. The leading cause of death in People with Type 2 Diabetes Mellitus (T2DM ) is CVD. T2DM doubles the risk of CVD compared with adults without T2DM.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.